--- title: "FTO, Freedom to Operate | MedTech Terms" description: "Analysis of whether a product can be sold without infringing third-party IP. Plain-English Commercialization definition for MedTech teams, with examples and rel" lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/freedom-to-operate#term", "name": "Freedom to Operate", "alternateName": "FTO", "description": "An FTO analysis identifies in-force third-party patent claims that could be infringed by a planned product, and assesses design-around or licensing options. Distinct from patentability - a company can have its own patent and still infringe another.", "url": "https://medtechterms.com/terms/freedom-to-operate", "termCode": "freedom-to-operate", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/freedom-to-operate#article", "headline": "FTO, Freedom to Operate", "description": "Analysis of whether a product can be sold without infringing third-party IP.", "url": "https://medtechterms.com/terms/freedom-to-operate", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/freedom-to-operate" }, "about": { "@id": "https://medtechterms.com/terms/freedom-to-operate#term" }, "articleSection": "Commercialization", "inLanguage": "en", "keywords": "Freedom to Operate, FTO, Commercialization, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "USPTO patent basics", "url": "https://www.uspto.gov/", "publisher": { "@type": "Organization", "name": "USPTO" } }, { "@type": "CreativeWork", "name": "AHRMM - Healthcare Supply Chain", "url": "https://www.ahrmm.org/", "publisher": { "@type": "Organization", "name": "AHRMM" } }, { "@type": "CreativeWork", "name": "AdvaMed Code of Ethics", "url": "https://www.advamed.org/our-work/code-of-ethics/", "publisher": { "@type": "Organization", "name": "AdvaMed" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/due-diligence#term", "name": "Due Diligence", "url": "https://medtechterms.com/terms/due-diligence" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Commercialization", "item": "https://medtechterms.com/terms?cat=Commercialization" }, { "@type": "ListItem", "position": 4, "name": "Freedom to Operate", "item": "https://medtechterms.com/terms/freedom-to-operate" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/freedom-to-operate#faq", "mainEntity": [ { "@type": "Question", "name": "How does Freedom to Operate differ from patentability?", "acceptedAnswer": { "@type": "Answer", "text": "Patentability refers to whether an invention meets the legal requirements to be granted a patent, such as novelty and non-obviousness. Freedom to Operate, conversely, assesses whether a product can be commercially manufactured, used, or sold without infringing on valid intellectual property rights of others." } }, { "@type": "Question", "name": "When should an FTO analysis be performed?", "acceptedAnswer": { "@type": "Answer", "text": "An FTO analysis should ideally be initiated early in the research and development phase to guide design choices and mitigate risks, and then periodically updated as the product evolves and prior art landscapes change." } }, { "@type": "Question", "name": "What are the consequences of not having FTO?", "acceptedAnswer": { "@type": "Answer", "text": "Without established FTO, a company faces potential lawsuits for patent infringement, which can result in costly legal fees, injunctions halting product sales, mandatory royalty payments, or significant damages awards." } }, { "@type": "Question", "name": "Can FTO impact regulatory submissions?", "acceptedAnswer": { "@type": "Answer", "text": "While FTO is not a direct part of regulatory submissions like 510(k) or PMA, unresolved infringement issues can disrupt a company's ability to reliably supply a product to market, which indirectly affects a manufacturer's compliance with quality system regulations and post-market obligations." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Commercialization](/terms?cat=Commercialization) 6. / 7. Freedom to Operate [All terms](/terms) Commercialization [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer)FTO # Freedom to Operate Analysis of whether a product can be sold without infringing third-party IP. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition An FTO analysis identifies in-force third-party patent claims that could be infringed by a planned product, and assesses design-around or licensing options. Distinct from patentability - a company can have its own patent and still infringe another. What the regulation says While not a direct regulatory requirement, maintaining freedom to operate is a de facto expectation for medical device manufacturers, as intellectual property disputes can disrupt supply chains and product availability, which falls under regulatory oversight regarding product quality and safety. Regulators like the FDA expect manufacturers to ensure consistent product supply and quality, which can be jeopardized by unresolved FTO issues. Though not explicitly stated in regulations like 21 CFR 820, the ability to legally market and distribute a device without infringement claims supports compliance with broader quality system requirements. ## What this means in practice Investor and acquirer DD requires clean FTO opinions. Late-stage FTO surprises can derail financings and [M&A](/terms/m-and-a). ## Examples - A startup developing a novel surgical robot conducts an FTO analysis to ensure its mechanical design and software algorithms do not infringe existing patents held by larger medical device companies. - Before launching a new diagnostic assay, a laboratory performs an FTO search to confirm that its reagents and testing methodology do not violate any in-force third-party patent claims. - A manufacturer planning to introduce a next-generation implantable device reviews the FTO landscape to identify potential infringement risks related to materials science or manufacturing processes. Common pitfalls - • Failing to conduct FTO analysis early in the product development lifecycle can lead to significant redesigns, delays, or even project cancellation. - • Assuming that obtaining your own patent guarantees freedom to operate is a common and dangerous misconception, as separate patents may exist that cover aspects of your device. - • Neglecting to update FTO analyses throughout the product lifecycle as new patents are granted or product designs evolve can expose a company to infringement risks. - • Relying solely on in-house legal opinions without seeking external expert review for complex FTO assessments can lead to overlooked risks. - • Ignoring FTO for software components or ancillary devices that integrate with the main MedTech product can create unexpected legal vulnerabilities. ## Frequently asked questions How does Freedom to Operate differ from patentability? Patentability refers to whether an invention meets the legal requirements to be granted a patent, such as novelty and non-obviousness. Freedom to Operate, conversely, assesses whether a product can be commercially manufactured, used, or sold without infringing on valid intellectual property rights of others. When should an FTO analysis be performed? What are the consequences of not having FTO? Can FTO impact regulatory submissions? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Investment & Finance Due Diligence Investigation of a company before an investment, financing, or acquisition. ](/terms/due-diligence) ### Founder & Investor Primer · From this learning path [ Regulatory Breakthrough Device Designation(BDD) FDA program providing expedited review for devices that treat life-threatening or irreversibly debilitating conditions. Adjacent lesson ](/terms/breakthrough-device?from=founder-and-investor-primer)[ Investment & Finance Series A / B / C Financing Rounds Sequential priced equity rounds in venture-backed companies, typically progressing from product-market validation (A) to scale (B) to growth (C+). Adjacent lesson ](/terms/series-funding?from=founder-and-investor-primer)[ Commercialization TAM / SAM / SOM Market sizing framework: total, serviceable available, and serviceable obtainable. ](/terms/tam-sam-som?from=founder-and-investor-primer)[ Regulatory 510(k) Premarket Notification(510(k)) FDA submission demonstrating a device is substantially equivalent to a legally marketed predicate. ](/terms/510k?from=founder-and-investor-primer) ### More in Commercialization · Same category [ Commercialization AdvaMed Code of Ethics Industry code governing interactions between U.S. medical-device companies and healthcare professionals. ](/terms/advamed-code)[ Commercialization Advisory Board Convening of external experts to advise on strategy or product. ](/terms/advisory-board)[ Commercialization Anti-Kickback Statute(AKS) U.S. criminal statute prohibiting remuneration to induce federal healthcare business. ](/terms/anti-kickback) Cited by Where this term appears across MedTech Terms. Learning paths (1) - [Founder & Investor Primer](/paths/founder-and-investor-primer)Lesson 6 of 16 Ecosystems (1) - [Hospital Buyer & Reimbursement](/ecosystems/hospital-buyer) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 USPTO· 1 AHRMM· 1 AdvaMed· 1 1. [1 USPTO patent basics Verified USPTO · uspto.gov ](https://www.uspto.gov/) 2. [2 AHRMM - Healthcare Supply Chain Verified AHRMM · ahrmm.org ](https://www.ahrmm.org/) 3. [3 AdvaMed Code of Ethics Verified AdvaMed · advamed.org ](https://www.advamed.org/our-work/code-of-ethics/) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Selling a connected device into health systems? Hospital procurement increasingly requires MDS2, SBOM, and security questionnaires - we help your team answer them confidently. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Commercialization Acronym FTO Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=freedom-to-operate) Learn in 60 seconds Card Lesson Quiz Analysis of whether a product can be sold without infringing third-party IP. - · Investor and acquirer DD requires clean FTO opinions. - · Late-stage FTO surprises can derail financings and M&A. - · Distinct from patentability - a company can have its own patent and still infringe another. Remember this Watch out: Failing to conduct FTO analysis early in the product development lifecycle can lead to significant redesigns, delays, or even project cancellation. Related terms - [Due Diligence ](/terms/due-diligence) You may also need Auto-suggested from Commercialization and shared keywords. - [409A Valuation ](/terms/409a-valuation) - [Algorithm Change Protocol(ACP) ](/terms/algorithm-change-protocol) - [Burn Rate and Runway ](/terms/burn-runway) - [Real-World Data(RWD) ](/terms/rwd) - [Distributor vs Direct Sales ](/terms/distributor-direct) - [Label Claims ](/terms/label-claims) [All Commercialization terms](/terms?cat=Commercialization) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)